Press Releases

September 10, 2021
IN8bio Reports Second Quarter 2021 Financial Results and Provides Corporate Update
PDF Version
August 30, 2021
IN8bio to Present at the NewYorkBIO Virtual Breakfast Series and H.C. Wainwright 23rd Annual Global Investment Conference
PDF Version
August 11, 2021
IN8bio Completes Dosing of First Cohort in Phase 1 Clinical Trial with Allogeneic Gamma Delta T-Cell Therapy in Leukemia Patients Undergoing Hematopoietic Stem Cell Transplant
PDF Version
August 4, 2021
IN8bio Appoints Emily Fairbairn and Luba Greenwood to Board of Directors
PDF Version
July 30, 2021
IN8bio Announces Pricing of Initial Public Offering
PDF Version